. Investor Presentation February 2021December 2020. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. Business / Finance Technology Economy. Investor Email Alerts. View Presentation View All Presentations. Furthermore, if the forward-looking statements . May 12, 2022. . STAMFORD, Conn., May 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that company management will participate at the following investor conferences: Live and archived webcasts of the presentations will be available on the "Events" section of the Sema4 . Formal presentation and 1x1s on Friday, February 18 th, 2022 at 2:20 p.m. Close. Investors and security holders of FWAA and SmartRent are urged to carefully read the entire proxy statement/prospectus, when it becomes available, and any other relevant documents filed with the SEC, as well as any amendments or supplements to these documents, because they will contain important information about the proposed transaction. STAMFORD, Conn., May 26, 2022 (GLOBE NEWSWIRE) -- Sema4 SMFR, an AI-driven genomic and clinical data intelligence platform company, today announced that. EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML. Furnished as Exhibit 99.2 hereto is an investor presentation, dated February 9, 2021, that will be used by the Company on a pre-recorded investor presentation regarding the Business Combination. Deep Dive Presentation 5.3 MB. Neither Sema4 nor the Company gives any assurance that either Sema4 or the Company or the combined company will achieve its expectations . CM Life Sciences Media Contact: Alexandria Fisk Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Copied. This Presentation contains projected financial information with respect to EVgo, namely gigawatt-hour throughput, revenue, free cash flow, adjusted EBITDA, adjusted EBITDA margin, capital expenditures and operating costs for 2020-2027. . Sema4 Holdings Corp is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Local; In Your Corner; Great State; Pay It 4ward; Health Quick Links. 3 Table of Contents Slide John Deere Strategy 4 Use-of-Cash 18 John Deere Financial Services 23 EX-99.2 7 ea135945ex99-2_eaststone.htm INVESTOR PRESENTATION Exhibit 99.2. 10-Q. May 11, 2022 at 12:20 PM EDT Click here for webcast. Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Our Story . Investor Relations Contact: Joel Kaufman Sema4 investors@sema4.com. Shift to Acquire Fair's Dealer Listing Marketplace Technology, Team to Expand E-commerce Auto Platform; SoftBank Group to Fully Fund Acquisition. CRIS and EVgo believe these non-GAAP measures of financial results provide useful information to . Investor Presentation August 2020 -October 2020. investors@sema4.com. Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. Business / Finance Technology Economy. new york, ny & stamford, ct — february 10, 2021 — sema4, an ai- and machine learning-driven patient-centered genomic and clinical data intelligence company, and cm life sciences (nasdaq: cmlf), a special purpose acquisition company, or spac, sponsored by affiliates of casdin capital, llc and corvex management lp, today announced they have entered … July 22, 2021 1:28 pm ET. After submitting your request, you will receive an activation email to the requested . View this Presentation PDF Format Download (opens in new window) PDF 4.32 MB Listen to this Presentation Audio Format Download . Stamford, CT 06902. ET / 9:20 a.m. PT; Live and archived webcasts of the presentations will be available on the "Events . Sema4 Investor Deck- May 2022 8.2 MB Sema4's Mission Sema4 - Mission Video Watch on Events Founders' Letter: Who we are— and why we exist. Read more March 14th, 2022 Shift Fourth Quarter and 2021 Earnings Call. Description. save. Sema4 Holdings Corp. 2021 Q4 - Results - Earnings Call Presentation SA Transcripts Mon, Mar. Sema4, a Disruptive AI-driven Genomic & Clinical Data Platform Company, to Combine with CM Life Sciences to Accelerate Growth. ET. Vote. Welcome to the Sema4 Holding Corp. 2022 Special Meeting of Stockholders. Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. stamford, ct — january 3, 2021 — sema4 (nasdaq: smfr), an ai-driven genomic and clinical data intelligence platform company, today announced that eric schadt, phd, founder and chief executive officer, and isaac ro, chief financial officer, will participate at the upcoming 40th annual j.p. morgan healthcare conference, which is taking place … . Presentation Date/Time: Thursday, June 16th, 2022 at 12:20 p.m. STAMFORD, Conn., May 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced. Home; World; Business. . Business / Finance Technology Economy. STAMFORD, Conn., May 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced. After submitting . . Primary Menu. Presentations Date Title; May 12, 2022. Forward-looking statements are statements that do not relate to historical facts and events and Ethics office says Annie Lamont is clear of conflicts. Sema4 to Participate at Two Investor Conferences in June 2022: GL. . Quarterly report which provides a continuing view of a company's financial position. ET. Fireside chat and 1x1s on Thursday, February 17 th, 2022 at 10:00 a.m. STAMFORD, Conn., May 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (NASDAQ:SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that company management will . Tags hide. Our telephone number is 800-298-6470 Disclaimer A Patient-Centered Health Intelligence Company Leveraging Genomics and AI Corporate Snapshot 4 Log in or sign up to leave a comment . User Walls. Partner Programs. On December 8, 2021, Dragoneer Growth Opportunities Corp. II consummated its previously announced business combination with Cvent. Presentation Date/Time: Thursday, June 16 th, 2022 at 12:20 p.m. TRANSACTION SUMMARY Note: Assumes no redemptions by Holicity's existing public shareholders. and must not be relied on by any investor or other person as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Sema4 Investor Relations Contact: David Deuchler Gilmartin Group investors@sema4.com. Sema4 to Participate at Two Investor Conferences in June 2022. Phone number 800-298-6470. EX-99.2 3 ea135108ex99-2_cmlifescience.htm INVESTOR PRESENTATION OF THE COMPANY ON FEBRUARY 9, 2021 Exhibit 99.2 . Mount Sinai, based in New York, was initially the sole investor and had a technology development agreement with Sema4 covering single-cell sequencing, long-read sequencing, and data analytics. Gateway Investor Relations Georg Venturatos T: (949) 574-3860 PCT@gatewayir.com. 0001818331-22-000046.rtf. This presentation is not an offer to sell or a solicitation of offers to buy any of Deere's securities. Jefferies London Healthcare Conference. Recent Event May 12, 2022 11:00 am EDT . 83.8 KB. STAMFORD, Conn., May 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that company management will participate at the following investor conferences: Conference: Jefferies Healthcare Conference Format: Fireside chat and 1x1s Presentation Date/Time: Thursday, June 9 th, 2022 at 8:30 a.m. Learn More ››› Latest News April 26th, 2022 ET; . Investor Presentation February 2021 A Leading FinTech Platform for the Everyday Consumer . Sema4 to Participate at Two Investor Conferences in June 2022. Home; World; Business. Tags 2 This presentation (together with oral statements made in connection herewith, this "Presentation") is provided for informational purposes only and has been prepared to assist interested parties in making their own evaluation with respect to a potential business combination between Wilco . sec.gov/Archiv. Shares of Sema4 Holdings Corp, a genetic-testing and health-data analytics business spun out of the Mount Sinai Health System, are . of Dragoneer related to its initial public offering and those under the heading "Summary Risk Factors" in the investor presentation filed as Exhibit 99.3 to Dragoneer's Current Report on Form 8-K filed on July 23, 2021. ET / 9:20 a.m. PT; Live and archived webcasts of the presentations will be available on the "Events . Requests for copies of such documents should be directed to our Investor Relations department at Sema4 Holdings Corp. 333 Ludlow Street, North Tower, 8thFloor, Stamford, CT 06902. User Walls. Print. SVB Leerink 11 th Annual Global Healthcare Conference. Sema4's plans are certainly ambitious aiming for a 3-year CAGR of 38% up from 2020's $190M in revenue, but still offers investors the right exposure to a growing industry in precision medicine. Formal presentation and 1x1s on Friday, February 18 th, 2022 at 2 . Investor Presentation December 2021 This presentation contains forward-looking statements under the meaning of the Private Securities Litigation Reform Act of 1995. Share this article. Yelp releases 2022 Top 100 Texas Restaurants list, … 16 hours ago Investor Relations; Content Library; Pricing; Sales: +1 (888) 993-8990; Contact Us; Get Started Free; Sign In; English English; Keywords. combination. 0 comments. Fireside chat and 1x1s on Thursday, November 18 th, 2021 at 11:30 a.m. STAMFORD, Conn., May 26, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, today announced that company management will . Address. 3.7 MB. Gov. 14 Sema4 Holdings Corp. SEC Filing - Annual Report (10-K) March 14, 2022 Sema4 J.P. Morgan Healthcare Conference Investor Presentation - SMFR SMFRW. Please enter a search term. 0001818331-22-000046.pdf. Sema4 is transforming healthcare by applying artificial intelligence and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. For more information, please visit sema4.com and connect with Sema4 on Twitter, LinkedIn, Facebook and YouTube. Investor Presentation 890.1 KB. Home; World; Business. Sema4 is a patient-centered health intelligence company dedicated to advancing healthcare through data-driven insights. share. Media Contact: Radley Moss Sema4 radley.moss@sema4.com. 100% Upvoted. SEC Filings; Investor FAQs; Information Request Form; IR Contact. Investors and security holders of Dragoneer are advised to read, . SVB Leerink 11 th Annual Global Healthcare Conference. Industries Real Estate 3D Photography Retail Home; World; Business. Past Events. Partner Programs Find a Reseller Partners Overview Software Developers Find a 3D Pro Industries. Biopharma Sema4 offers an extensive portfolio of health information solutions, including pre-clinical and clinical trial support, analytics for actionable insights, and advanced sequencing services, to drive informed decision-making across the drug discovery, development, and commercialization lifecycle. Bank of America 2022 Healthcare Conference . Investor Presentation. 05/16: Cowen Adjusts Sema4 Holdings' Price Target to $5 from $13, Keeps Outperform Rating: MT. Ned Lamont's spouse, Annie Lamont, is a founder and managing partner of Oak HC/FT, a venture capital firm that twice invested in Sema4. Sema4 4Q and Full Year 2021 Earnings Deck 1.7 MB. Sema4 Investor Deck - May 2022 8.2 MB. Sema4 to Participate at Two Investor Conferences in June 2022. This investor presentation (this "Presentation") is provided for informational purposes only and has been prepared to assist interested parties in making their own evaluation with respect to a potential business combination between Papay Topco, Inc. ("Cvent") and Dragoneer Growth Opportunities Corp. II ("Dragoneer") and related . investors@sema4.com . ET / 9:20 a.m. PT Live and archived webcasts of the presentations will be available on the "Events" section of the Sema4 . • Holicity (NASDAQ:HOL) is a SPAC with ~$300M cash held in trust, 1/3 warrant structure • PIPE investors to commit $200M concurrent with transaction announcement OFFERING SIZE PRO FORMA CAPITAL STRUCTURE • Astra will receive ~$489M in cash as a result of the transactions (including Series C) investors@sema4.com. March 15, 2022 at 2:00 PM PDT. User Walls. This Management Presentation (this "Presentation") has been prepared by LiveVox, Inc. and its affiliates (collectively, "LiveVox" or "Company") and Crescent Acquisition Corp ("Crescent") in connection with a proposed business combination involving Crescent and LiveVox as further described herein (the "Transaction"). Presentation Date/Time: Thursday, June 16 th, 2022 at 12:20 p.m. | May 26, 2022 Our telephone number is 800 -298-6470 3 Overview Financials Strategy Q&A Agenda 4 Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Compounds derived from Shattuck's ARC platform simultaneously inhibit checkpoint molecules and activate costimulatory . STAMFORD, Conn., May 26, 2022 -- Sema4 , an AI-driven genomic and clinical data intelligence platform company, today announced that company management will participate at the following investor. statements, and other information concerning us is available at http:// www.sec.gov. Fireside chat and 1x1s on Thursday, February 17 th, 2022 at 10:00 a.m. ET; . More results . 2 Safe Harbor Statement & Disclosures . Requests for copies of such documents should be directed to our Investor Relations department at Sema4 Holdings Corp. 333 Ludlow Street, North Tower, 8thFloor, Stamford, CT 06902. STAMFORD, Conn., May 26, 2022 (GLOBE NEWSWIRE) -- Sema4 SMFR, an AI-driven genomic and clinical data intelligence platform company, today announced that. Transfer Agent. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Press Release. A Sema4 office in Branford. Corporate Headquarters. report. Text. News. This Presentation contains certain "forward‐looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the . Presentation Date/Time: Thursday, June 16th, 2022 at 12:20 p.m. Was it improper for her firm to increase its stake in Sema4 after the state's COVID testing contract lifted the company's testing volume and boosted its revenue? This presentation has been prepared for use by Bridgetown and PropertyGuru, and is intended solely for investors that are qualified institutional buyers (as defined in Rule 144A under the U.S. Securities Act of 1933, as amended (the "Securities Act")) and eligible institutional investors outside the U.S. (such Contact us at: 786-360-4768 IR@caremax.com. 333 Ludlow Street, North Tower, 8th floor. Shift Q4 Shareholder Letter. maria.armental@wsj.com. ET. Investor Presentation. STAMFORD, CT — May 24, 2021 — Sema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights, today announced that members of the Sema4 management team will participate in a fireside chat an upcoming virtual investor conference. investors@sema4.com . Many actual events and circumstances are beyond . Matterport - Capture, share, and collaborate the built world in . User Walls. 1 CONFIDENTIAL JHD HOLDINGS LIMITED Merchant Enablement Services platform for lower tier China, one of the world's largest emerging markets February 2021 jhdholdings.com EAST STONE ACQUISITION CORPORATION Media Contact: Radley Moss Sema4 radley.moss@sema4.com. Spun out of Mount Sinai in 2017, Sema4 has always targeted an integration of genetic testing and data science. Sema4 to Participate at Two Investor Conferences in June 2022. Continental Stock Transfer & Trust Company 1 State Street, 30th Floor March 14, 2022. Posted by 6 minutes ago. It is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal . The documents filed by Sema4 with the SEC also may be obtained free of charge at Sema4's investor relations portion of its website at www.sema4.com or upon written request to Sema4 Holdings Corp., 333 Ludlow Street, North Tower, 8th Floor, Stamford, Connecticut, 06902. Click here for webcast. Participants in Solicitation Live and archived webcasts of the Stifel . Sema4 J.P. Morgan Healthcare Conference Investor Presentation - SMFR SMFRW. This Investor Presentation (the "Investor Presentation"), which is to be used by the WL Ross Holding Corp. ("WLRH") in making presentations to certain of its stockholders and other persons with respect to the transactions contemplated by the merger agreement previously announced on March 21, supersedes the investor presentation provided on . 1 R: 77 G: 136 B: 199 R: 44 G: 103 B: 161 R: 79 G: 97 B: 112 R: 201 G: 48 B: 44 . Sema4 is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. ET / 9:20 a.m. PT Live and archived webcasts of the presentations will be available on the "Events" section of the Sema4 . View All. http://www.sec.gov. 05/13: Sema4 Holdings' Q1 Loss Narrows, Revenue Falls . Latest Presentation May 11, 2022 . Quarterly Filings. Latest Events & Presentation. Business / Finance Technology Economy. Media Contact . Live and archived webcasts of the presentations will be available on the"Events" section of the Sema4 investor relations website at . Investor Presentation March 2021 1. . Formal presentation and 1x1s on Friday, February 18 th, 2022 at 2:20 p.m. Main Health News Today. 1x1s on Friday, November 19 th, 2021. March 16th, 2022 Sema4 Announces Nationwide Expansion of Disparity Study to Deliver Precision Oncology Care to Underserved Communities Sema4's study will create one of the most diverse and comprehensive clinico-genomic datasets to uncover and address disparities in cancer care. To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. Presentation Operator MessageOperator Good morning. Sema4 is a patient-centered health . ET File. February 10, 2021, 12:00 PM UTC. This presentation is for information purposes only and is being provided to you solely in your capacity as a potential investor in considering an investment in Social Capital and may not be reproduced or redistributed, in whole or in part, without the prior written consent of Social Capital and Clover. Matterport Presentation 2021_1.pdf. 0001818331-22-000046.xls. Formal presentation and 1x1s on Friday, February 18 th, 2022 at 2 . About Sema4 . Sema4 Media Contact: Radley Moss Sema4 radley.moss@sema4.com. The Investor Relations website contains information about T Q1 2022 Clover Health Earnings Conference Call. First Quarter 2022 Corporate Update .